Inhibiting amyloid-β cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design
- 8 October 2018
- journal article
- research article
- Published by Springer Nature in Nature Chemistry
- Vol. 10 (12) , 1213-1221
Abstract
Inhibiting the interaction between amyloid-β (Aβ) and a neuronal cell surface receptor, LilrB2, has been suggested as a potential route for treating Alzheimer’s disease. Supporting this approach, Alzheimer’s-like symptoms are reduced in mouse models following genetic depletion of the LilrB2 homologue. In its pathogenic, oligomeric state, Aβ binds to LilrB2, triggering a pathway to synaptic loss. Here we identify the LilrB2 binding moieties of Aβ (16KLVFFA21) and identify its binding site on LilrB2 from a crystal structure of LilrB2 immunoglobulin domains D1D2 complexed to small molecules that mimic phenylalanine residues. In this structure, we observed two pockets that can accommodate the phenylalanine side chains of KLVFFA. These pockets were confirmed to be 16KLVFFA21 binding sites by mutagenesis. Rosetta docking revealed a plausible geometry for the Aβ–LilrB2 complex and assisted with the structure-guided selection of small molecule inhibitors. These molecules inhibit Aβ–LilrB2 interactions in vitro and on the cell surface and reduce Aβ cytotoxicity, which suggests these inhibitors are potential therapeutic leads against Alzheimer’s disease.Keywords
This publication has 44 references indexed in Scilit:
- Amyloid β-sheet mimics that antagonize protein aggregation and reduce amyloid toxicityNature Chemistry, 2012
- Toxic fibrillar oligomers of amyloid-β have cross-β structureProceedings of the National Academy of Sciences, 2012
- Molecular basis for amyloid-β polymorphismProceedings of the National Academy of Sciences of the United States of America, 2011
- Prolonged Exposure of Cortical Neurons to Oligomeric Amyloid-β Impairs NMDA Receptor Function Via NADPH Oxidase-Mediated ROS Production: Protective Effect of Green Tea (-)-Epigallocatechin-3-GallateASN Neuro, 2011
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer modelNature, 2010
- Probing the Biology of Alzheimer's Disease in MiceNeuron, 2010
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008
- 3D structure of Alzheimer's amyloid-β(1–42) fibrilsProceedings of the National Academy of Sciences, 2005
- Shape Complementarity at Protein/Protein InterfacesJournal of Molecular Biology, 1993